Guo and colleagues showed that the siRNA silencing of Lcn-2 in a TNBC model inhibited angiogenesis in vivo and in vitro, while in a similar study on IBC, the depletion of Lcn-2 in cell cultures reduced invasion, migration, and the cancer stem cell population [105,106]. The gene discussed is LCN2; the disease is inflammatory breast carcinoma.